Bringing the fundamentals into focus…
Back to Regeneron Pharmaceuticals, Inc.
How Regeneron Pharmaceuticals, Inc. stacks up
REGN · against 37 other Healthcare companies of similar size
Growth
49/ 100
Below the middle of the pack.
Ranked #25 of 38 · scores higher than 32% of peers
Bars: peers in each 10-point band of the growth score9 peers with a growth score of 40–49, including REGN · Click a bar to see the companies
Why growth scores 49?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- slower growth in earnings per share: weaker than 62% of peers. Earnings per share growth: -0.5% vs peer median 9.8%
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 7.0% vs peer median 5.8%
- Revenue growth is close to the peer norm. Revenue growth: 9.3% vs peer median 6.1%
Metric by metric
Position: dot = REGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | REGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 38 reported | 9.3% | 8.3% | 57% | 33% | |
| Earnings per share growthHigher is better · 33 reported | -0.5% | 17.4% | 25% | 33% | |
| 3-year revenue growthHigher is better · 38 reported | 7.0% | 6.8% | 54% | 33% |
Ranking by growth score
Top 5 and the companies ranked around REGN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 56.7B USD | 96 | 79 | |
| 2 | 56.0B USD | 86 | 39 | |
| 3 | 126.5B USD | 78 | 56 | |
| 4 | 534.1B HKD (≈$68.4B) | 76 | 75 | |
| 4 | 52.7B EUR (≈$58.0B) | 76 | 71 | |
| 22 | 108.6B USD | 55 | 66 | |
| 22 | 4.25T INR (≈$51.0B) | 55 | 70 | |
| 24 | 100.2B USD | 54 | 57 | |
| 25 | 116.9B USD | 49 | 47 | |
| 25 | 100.2B USD | 49 | 68 | |
| 27 | 161.8B USD | 47 | 50 | |
| 28 | 54.0B USD | 45 | 47 | |
| 28 | 89.7B USD | 45 | 50 | |
| 30 | 11.26T JPY (≈$76.6B) | 44 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score